To study the influence of suspending agents on the relative bioavailability of Cyclosporine A-loaded HPMCP(HP55) nanoparticles for oral administration.Suspending agents such as Vanzan, HPMC, Carbopol were added into cyclosporine A-loaded HP55 nanoparticles. The suspended nanoparticle formulations and Neoral were administered orally in a dosage of 15 mg/kg to rats. The CyA concentrations in the blood sample were determined by HPLC. Pharmacokinetic parameters were calculated by 3P97.The concentration-time data of these preparations were best fit by two compartment model with a weight of 1/C(2). Compared with the reference Neoral microemulsion, the relative bioavailability of 2 g/L Carbopol, 5 g/L Vanzan, 8, 5, 3 g/L HPMC suspended nanoparticl...
AbstractThe modelling pharmacokinetic profile of freeze-dried cyclosporine A-Eudragit S100 nanoparti...
The present study was aimed at preparation and performance evaluation of pH-sensitive cyclosporine A...
The bioavailability of two microemulsion formulations of cyclosporine (Drug A, cyclosporine Neoral
The pH-sensitive cyclosporine A (CyA) nanoparticles were prepared by the solvent displacement method...
The purpose of this work was to improve the oral bioavailability of cyclosporine A (CyA) by preparat...
The present study was geared at the long-term stability and the changes in oral bioavailability of C...
Biodegradable nanoparticles are being considered more often as drug carriers to address pharmacokine...
Biodegradable nanoparticles are being considered more often as drug carriers to address pharmacokine...
Theophylline-loaded polyisobutylcyanoacrylate (PICA) nanoparticles were prepared by emulsifier-free ...
Cyclosporine A-nanosuspensions were prepared using zirconium oxide beads as a milling media, Poloxam...
目的研究环孢素A聚乳酸纳米粒胶体(CyA-NP)的制备处方与工艺,并以新山地明(Neoral)为参比制剂,进行相对生物利用度考察.方法以溶剂-非溶剂法制备CyA-NP,用HPLC法测定全血中的药物浓度...
Cyclosporine (CsA) as an immunosuppressant has demonstrated immense potential in the field of organ ...
Jie Lai1,2, Yi Lu1, Zongning Yin2, Fuqiang Hu3, Wei Wu11School of Pharmacy, Fudan University, Shangh...
The purpose of this study was to evaluate the potential of new carboxylated multiblock copolymer of ...
The purpose of this study was to evaluate the potential of new carboxylated multi-block copolymer of...
AbstractThe modelling pharmacokinetic profile of freeze-dried cyclosporine A-Eudragit S100 nanoparti...
The present study was aimed at preparation and performance evaluation of pH-sensitive cyclosporine A...
The bioavailability of two microemulsion formulations of cyclosporine (Drug A, cyclosporine Neoral
The pH-sensitive cyclosporine A (CyA) nanoparticles were prepared by the solvent displacement method...
The purpose of this work was to improve the oral bioavailability of cyclosporine A (CyA) by preparat...
The present study was geared at the long-term stability and the changes in oral bioavailability of C...
Biodegradable nanoparticles are being considered more often as drug carriers to address pharmacokine...
Biodegradable nanoparticles are being considered more often as drug carriers to address pharmacokine...
Theophylline-loaded polyisobutylcyanoacrylate (PICA) nanoparticles were prepared by emulsifier-free ...
Cyclosporine A-nanosuspensions were prepared using zirconium oxide beads as a milling media, Poloxam...
目的研究环孢素A聚乳酸纳米粒胶体(CyA-NP)的制备处方与工艺,并以新山地明(Neoral)为参比制剂,进行相对生物利用度考察.方法以溶剂-非溶剂法制备CyA-NP,用HPLC法测定全血中的药物浓度...
Cyclosporine (CsA) as an immunosuppressant has demonstrated immense potential in the field of organ ...
Jie Lai1,2, Yi Lu1, Zongning Yin2, Fuqiang Hu3, Wei Wu11School of Pharmacy, Fudan University, Shangh...
The purpose of this study was to evaluate the potential of new carboxylated multiblock copolymer of ...
The purpose of this study was to evaluate the potential of new carboxylated multi-block copolymer of...
AbstractThe modelling pharmacokinetic profile of freeze-dried cyclosporine A-Eudragit S100 nanoparti...
The present study was aimed at preparation and performance evaluation of pH-sensitive cyclosporine A...
The bioavailability of two microemulsion formulations of cyclosporine (Drug A, cyclosporine Neoral